Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
CLUPEA is a South Korea-based healthcare IT company focused on clinical and nonclinical trial data management software. Its core product, MediLake, is an AI-enabled eClinical platform that supports electronic data capture, clinical data management, ePRO, eConsent, eTMF, IWRS, and CDISC-compliant workflows for pharmaceutical, biotech, CRO, and research customers. The company also offers a SEND-focused platform for nonclinical data standardization and regulatory submission workflows. CLUPEA appears to operate as a software and data infrastructure provider rather than a therapeutics developer, with services centered on regulatory-compliant research data operations and healthcare data R&D. The company markets its platform for faster study buildout, improved data quality, and submission-readiness across major regulatory jurisdictions.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on CLUPEA.